As of 2026-01-03, the Relative Valuation of Sana Biotechnology Inc (SANA) is (14.26) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.19 USD, the upside of Sana Biotechnology Inc based on Relative Valuation is -440.2%.
The range of the Relative Valuation is (13.20) - (15.66) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.9x - 17.8x | 15.8x |
| Forward P/E multiples | 15.0x - 18.1x | 16.6x |
| Fair Price | (13.20) - (15.66) | (14.26) |
| Upside | -415.0% - -473.8% | -440.2% |
| Date | P/E |
| 2025-12-31 | -4.62 |
| 2025-12-30 | -4.64 |
| 2025-12-29 | -4.68 |
| 2025-12-26 | -5.01 |
| 2025-12-24 | -5.15 |
| 2025-12-23 | -5.15 |
| 2025-12-22 | -5.19 |
| 2025-12-19 | -4.95 |
| 2025-12-18 | -5.11 |
| 2025-12-17 | -5.43 |
| 2025-12-16 | -5.68 |
| 2025-12-15 | -5.77 |
| 2025-12-12 | -5.84 |
| 2025-12-11 | -5.68 |
| 2025-12-10 | -5.61 |
| 2025-12-09 | -4.94 |
| 2025-12-08 | -5.26 |
| 2025-12-05 | -5.83 |
| 2025-12-04 | -5.89 |
| 2025-12-03 | -5.08 |
| 2025-12-02 | -4.51 |
| 2025-12-01 | -4.55 |
| 2025-11-28 | -4.89 |
| 2025-11-26 | -4.57 |
| 2025-11-25 | -3.99 |
| 2025-11-24 | -4.02 |
| 2025-11-21 | -3.74 |
| 2025-11-20 | -3.67 |
| 2025-11-19 | -3.86 |
| 2025-11-18 | -4.01 |
| 2025-11-17 | -4.14 |
| 2025-11-14 | -4.53 |
| 2025-11-13 | -4.16 |
| 2025-11-12 | -4.61 |
| 2025-11-11 | -4.82 |
| 2025-11-10 | -4.68 |
| 2025-11-07 | -4.65 |
| 2025-11-06 | -4.60 |
| 2025-11-05 | -4.64 |
| 2025-11-04 | -4.72 |
| 2025-11-03 | -5.19 |
| 2025-10-31 | -5.62 |
| 2025-10-30 | -5.57 |
| 2025-10-29 | -6.10 |
| 2025-10-28 | -6.35 |
| 2025-10-27 | -5.97 |
| 2025-10-24 | -6.35 |
| 2025-10-23 | -6.35 |
| 2025-10-22 | -6.25 |
| 2025-10-21 | -6.49 |